Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar desktop iconMarkt Monitor

Aandeel Celyad BRU:CYAD.BL, BE0974260896

Laatste koers (eur) Verschil Volume
0,350   +0,055   (+18,64%) Dagrange 0,300 - 0,370 144.148   Gem. (3M) 20,7K

Celyad 2022

1.908 Posts
Pagina: «« 1 ... 85 86 87 88 89 ... 96 »» | Laatste | Omlaag ↓
  1. Dannyb44 10 november 2022 08:11
    After due consideration of detailed budgets and estimated cash flow forecasts for the years 2022 and 2023 which reflect the current strategy of the Company and include expenses and cash outflows estimations in relation to the development of discretionary research programs and pipeline of products candidates, the Company continues to project that its existing cash and cash equivalents will not be sufficient to fund its estimated operating and capital expenditures over at least the next 12 months from the date that the release is issued.
  2. Garre 22 november 2022 17:23
    Thank you for your email. For sure I understand that this is difficult to wait for the news…researches in the biotech take long time before any communication could be done on the results…

    The only advice I could give is to be patient. Communications on the evolution of the Celyad studies and research will be provided in the coming weeks.



    Thank you for your patience and understanding.
1.908 Posts
Pagina: «« 1 ... 85 86 87 88 89 ... 96 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.